KTTAW
Pasithea Therapeutics Corp. NASDAQ$0.01
Mkt Cap $52,839
52w Low $0.01
3.8% of range
52w High $0.01
50d MA $0.01
200d MA $0.02
P/E (TTM)
0.0x
EV/EBITDA
2.3x
P/B
0.0x
Debt/Equity
0.0x
ROE
—
P/FCF
-0.0x
RSI (14)
—
ATR (14)
—
Beta
0.25
50d MA
$0.01
200d MA
$0.02
Avg Volume
33.3K
About
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach,…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | -0.18 | -0.79 | -338.9% | 0.01 | +0.0% | +0.0% | -52.3% | +60.6% | +5.5% | -34.9% | -35.8% | — |
| Feb 25, 2026 | AMC | -0.18 | -0.18 | +0.0% | — | — | — | — | — | — | — | — | — |
| Nov 13, 2025 | AMC | — | -408.04 | — | — | — | — | — | — | — | — | — | — |
| Aug 14, 2025 | AMC | — | -0.66 | — | — | — | — | — | — | — | — | — | — |
| May 15, 2025 | AMC | — | -1.61 | — | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -0.00 | — | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | -0.14 | — | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | -10.55 | — | — | — | — | — | — | — | — | — | — |
| Dec 31, 2022 | AMC | — | -0.15 | — | — | — | — | — | — | — | — | — | — |
Recent Filings
Data updated apr 28, 2026 1:43pm
· Source: massive.com